Following hospital discharge, patients with multisystem inflammatory syndrome in children (MIS-C) had worse outcomes in areas of neurology, working memory, depression, and quality of life.
Study co-authored by Intermountain Primary Children's Hospital physician is the nation's first longitudinal study to understand how MIS-C is affecting children long-term.
Vaccination against COVID-19 appears to be safe for children who have had multisystem inflammatory syndrome in children (MIS-C) and does not appear to increase the risk for inflammation of the heart or other organs, suggests a small study funded by the National Institutes of Health.
The Virginia Department of Health has confirmed a death from Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19. This is the first death from MIS-C reported in Virginia. The child was between 10 and 19 years old and resided in the Prince William Health District.
Multisystem Inflammatory Syndrome in Children (MIS-C) can lead to a multi-organ failure affecting the heart, lung, liver, and brain. Therefore, early detection of the syndrome is necessary.
email article
Early in the pandemic, many hospitals, especially in the hard-hit Northeast, created dedicated and ongoing care for COVID-19 patients with lingering symptoms.
Now, as vaccination rates increase and new infections decline, some facilities are looking to wind down their post-COVID care centers. When they're no longer needed, that would signal success. And it's important for hospitals to get back to their usual business.
At the same time, other facilities are turning their attention to different areas of longer-term care, such as dedicated spaces to monitor the after-effects of infection in children.
Regardless, hospitals continue to monitor current needs.